Loading
Agaricus blazei is a Brazilian mushroom sold in Japan and elsewhere as a cancer remedy. Small studies suggest better quality of life during chemotherapy, but none showed longer survival, and liver damage and deaths have been reported in people taking it. Some samples contained high levels of arsenic.
Agaricus blazei Murrill is an edible mushroom cultivated in Japan for medicinal use. Memorial Sloan Kettering's About Herbs page reports antidiabetic and antiproliferative effects in the laboratory and limited human studies: better natural killer cell activity and quality of life in women with gynaecological cancers on chemotherapy, better quality of life in people in remission, and immune changes without survival improvement in multiple myeloma; it gave no benefit in elderly women. Against that, MSK records liver damage and deaths following consumption, an association with hepatic dysfunction in cancer patients, cheilitis, and laboratory samples with high levels of inorganic arsenic. The extract has oestrogen-like activity in vitro, so people with hormone-sensitive cancers are advised to discuss it with their doctor, and it inhibits CYP3A4 in vitro, which could raise levels of drugs cleared by that enzyme. The grade reflects the reported liver injury and contamination.
Beta-glucans and other polysaccharides with immune and antiangiogenic effects in laboratory models.
Query for this technology: (TITLE:"Agaricus blazei mushroom" OR ABSTRACT:"Agaricus blazei mushroom") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Agaricus blazei mushroom, not a curated reading list.
Shares AHCC (active hexose correlated compound), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Unproven diet claims (alkaline, juice, 'anti-cancer' diets), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Unproven diet claims (alkaline, juice, 'anti-cancer' diets), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Unproven diet claims (alkaline, juice, 'anti-cancer' diets), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Unproven diet claims (alkaline, juice, 'anti-cancer' diets), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Unproven diet claims (alkaline, juice, 'anti-cancer' diets), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares MGN-3 (rice bran arabinoxylan, BioBran), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology and the tags complementary, supportive-care.
Shares Unproven diet claims (alkaline, juice, 'anti-cancer' diets), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/